{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T16:52:36Z","timestamp":1780419156641,"version":"3.54.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2021,5,29]],"date-time":"2021-05-29T00:00:00Z","timestamp":1622246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,29]],"date-time":"2021-05-29T00:00:00Z","timestamp":1622246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002996","name":"Hartstichting","doi-asserted-by":"publisher","award":["CVON 2015-21"],"award-info":[{"award-number":["CVON 2015-21"]}],"id":[{"id":"10.13039\/501100002996","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001827","name":"Universiteit van Amsterdam","doi-asserted-by":"publisher","award":["8367"],"award-info":[{"award-number":["8367"]}],"id":[{"id":"10.13039\/501100001827","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2021,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>As in other cardiomyopathies, extracellular matrix (ECM) remodeling plays an important role in anthracycline-induced cardiomyopathy. To understand the pattern and timing of ECM remodeling pathways, we conducted a systematic review in which we describe protein and mRNA markers for ECM remodeling that are differentially expressed in the hearts of animals with anthracycline-induced cardiomyopathy. We included 68 studies in mice, rats, rabbits, and pigs with follow-up of 0.1\u20138.2 human equivalent years after anthracycline administration. Using meta-analysis, we found 29 proteins and 11 mRNAs that were differentially expressed in anthracycline-induced cardiomyopathy compared to controls. Collagens, matrix metalloproteinases (MMPs), inflammation markers, transforming growth factor \u00df signaling markers, and markers for cardiac hypertrophy were upregulated, whereas the protein kinase B (AKT) pro-survival pathway was downregulated. Their expression patterns over time from single time point studies were studied with meta-regression using human equivalent years as the time scale. Connective tissue growth factor showed an early peak in expression but remained upregulated at all studied time points. Brain natriuretic peptide (BNP) and MMP9 protein levels increased in studies with longer follow-up. Significant associations were found for higher atrial natriuretic peptide with interstitial fibrosis and for higher BNP and MMP2 protein levels with left ventricular systolic function.<\/jats:p>","DOI":"10.1007\/s00109-021-02098-8","type":"journal-article","created":{"date-parts":[[2021,5,29]],"date-time":"2021-05-29T20:02:41Z","timestamp":1622318561000},"page":"1195-1207","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Extracellular matrix remodeling in animal models of anthracycline-induced cardiomyopathy: a meta-analysis"],"prefix":"10.1007","volume":"99","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9413-8478","authenticated-orcid":false,"given":"Jan M.","family":"Leerink","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mabel","family":"van de Ruit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.M.","family":"Feijen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leontien C.M.","family":"Kremer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annelies M.C.","family":"Mavinkurve-Groothuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yigal M.","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther E.","family":"Creemers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wouter E.M.","family":"Kok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,29]]},"reference":[{"issue":"1","key":"2098_CR1","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S1470-2045(13)70548-5","volume":"15","author":"G Gatta","year":"2014","unstructured":"Gatta G, Botta L, Rossi S, Aareleid T, Bielska-Lasota M, Clavel J, Dimitrova N, Jakab Z, Kaatsch P, Lacour B, Mallone S, Marcos-Gragera R, Minicozzi P, Sanchez-Perez MJ, Sant M, Santaquilani M, Stiller C, Tavilla A, Trama A, Visser O, Peris-Bonet R (2014) Childhood cancer survival in Europe 1999-2007: results of EUROCARE-5--a population-based study. The Lancet Oncology 15(1):35\u201347","journal-title":"The Lancet Oncology"},{"issue":"1","key":"2098_CR2","doi-asserted-by":"publisher","first-page":"e009122","DOI":"10.1161\/JAHA.118.009122","volume":"8","author":"EAM Feijen","year":"2019","unstructured":"Feijen EAM, Font-Gonzalez A, Van der Pal Helena JH, Kok Wouter EM, Geskus Ronald B, Ronckers C\u00e9cile M, Bresters D, van Dalen EC, van Dulmen-den Broeder E, van den Berg MH, van der Heiden-van der Loo M, van den Heuvel-Eibrink MM, van Leeuwen FE, Loonen Jacqueline J, Neggers Sebastian JCMM, Versluys AB, Tissing Wim JE, Kremer Leontien CM, Null N, Dolsma W, Grootenhuis MA, den Hartogh JG, MWM J, Postma A, Hollema N, Kok JL, Teepen JC, de Ridder JG, Caron HN, van der Meer P (2019) Risk and temporal changes of heart failure among 5-year childhood cancer survivors: a DCOG-LATER study. J Am Heart Assoc 8(1):e009122","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"2098_CR3","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1161\/CIRCRESAHA.115.303633","volume":"118","author":"CG Lenneman","year":"2016","unstructured":"Lenneman CG, Sawyer DB (2016) Cardio-oncology: an update on cardiotoxicity of cancer-related treatment. Circ Res 118(6):1008\u20131020","journal-title":"Circ Res"},{"issue":"6","key":"2098_CR4","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1016\/j.yjmcc.2012.03.006","volume":"52","author":"Y Octavia","year":"2012","unstructured":"Octavia Y, Tocchetti CG, Gabrielson KL, Janssens S, Crijns HJ, Moens AL (2012) Doxorubicin-induced cardiomyopathy: from molecular mechanisms to therapeutic strategies. J Mol Cell Cardiol 52(6):1213\u20131225","journal-title":"J Mol Cell Cardiol"},{"key":"2098_CR5","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1038\/nm.2919","volume":"18","author":"S Zhang","year":"2012","unstructured":"Zhang S, Liu X, Bawa-Khalfe T, Lu L-S, Lyu YL, Liu LF, Yeh ETH (2012) Identification of the molecular basis of doxorubicin-induced cardiotoxicity. Nat Med 18:1639\u20131642","journal-title":"Nat Med"},{"issue":"1","key":"2098_CR6","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1161\/CIRCRESAHA.119.311148","volume":"125","author":"NG Frangogiannis","year":"2019","unstructured":"Frangogiannis NG (2019) The extracellular matrix in ischemic and nonischemic heart failure. Circ Res 125(1):117\u2013146","journal-title":"Circ Res"},{"issue":"2","key":"2098_CR7","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1093\/cvr\/cvq308","volume":"89","author":"EE Creemers","year":"2011","unstructured":"Creemers EE, Pinto YM (2011) Molecular mechanisms that control interstitial fibrosis in the pressure-overloaded heart. Cardiovasc Res 89(2):265\u2013272","journal-title":"Cardiovasc Res"},{"key":"2098_CR8","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.yjmcc.2013.10.019","volume":"70","author":"J Davis","year":"2014","unstructured":"Davis J, Molkentin JD (2014) Myofibroblasts: trust your heart and let fate decide. J Mol Cell Cardiol 70:9\u201318","journal-title":"J Mol Cell Cardiol"},{"issue":"7","key":"2098_CR9","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1161\/CIRCRESAHA.116.302317","volume":"116","author":"DL Mann","year":"2015","unstructured":"Mann DL (2015) Innate immunity and the failing heart: the cytokine hypothesis revisited. Circ Res 116(7):1254\u20131268","journal-title":"Circ Res"},{"issue":"2","key":"2098_CR10","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1002\/ehf2.12616","volume":"7","author":"R Tanaka","year":"2020","unstructured":"Tanaka R, Umemura M, Narikawa M, Hikichi M, Osaw K, Fujita T, Yokoyama U, Ishigami T, Tamura K, Ishikawa Y (2020) Reactive fibrosis precedes doxorubicin-induced heart failure through sterile inflammation. ESC Heart Failure 7(2):588\u2013603","journal-title":"ESC Heart Failure"},{"issue":"5","key":"2098_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0096055","volume":"9","author":"O Lencova-Popelova","year":"2014","unstructured":"Lencova-Popelova O, Jirkovsky E, Mazurova Y, Lenco J, Adamcova M, Simunek T, Gersl V, Sterba M (2014) Molecular remodeling of left and right ventricular myocardium in chronic anthracycline cardiotoxicity and post-treatment follow up. PLoS One 9(5):e96055. https:\/\/doi.org\/10.1371\/journal.pone.0096055","journal-title":"PLoS One"},{"issue":"2","key":"2098_CR12","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.jaccao.2020.04.011","volume":"2","author":"I Harries","year":"2020","unstructured":"Harries I, Liang K, Williams M, Berlot B, Biglino G, Lancellotti P, Plana JC, Bucciarelli-Ducci C (2020) Magnetic resonance imaging to detect cardiovascular effects of cancer therapy. JACC CardioOncology 2(2):270\u2013292","journal-title":"JACC CardioOncology"},{"issue":"4","key":"2098_CR13","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/aps.2011.194","volume":"33","author":"M Ivanova","year":"2012","unstructured":"Ivanova M, Dovinova I, Okruhlicova L, Tribulova N, Simoncikova P, Barte-Kova M, Vlkovicova J, Barancik M (2012) Chronic cardiotoxicity of doxorubicin involves activation of myocardial and circulating matrix metalloproteinases in rats. Acta Pharmacol Sin 33(4):459\u2013469","journal-title":"Acta Pharmacol Sin"},{"issue":"4","key":"2098_CR14","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.pharep.2019.02.013","volume":"71","author":"DJM Medeiros-Lima","year":"2019","unstructured":"Medeiros-Lima DJM, Carvalho JJ, Tibirica E, Borges JP, Matsuura C (2019) Time course of cardiomyopathy induced by doxorubicin in rats. Pharmacological reports : PR 71(4):583\u2013590","journal-title":"Pharmacological reports : PR"},{"issue":"4","key":"2098_CR15","doi-asserted-by":"publisher","first-page":"R1075","DOI":"10.1152\/ajpregu.00360.2009","volume":"298","author":"M Tokarska-Schlattner","year":"2010","unstructured":"Tokarska-Schlattner M, Lucchinetti E, Zaugg M, Kay L, Gratia S, Guzun R, Saks V, Schlattner U (2010) Early effects of doxorubicin in perfused heart: transcriptional profiling reveals inhibition of cellular stress response genes. Am J Physiol Regul Integr Comp Physiol 298(4):R1075\u2013R1088","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"3","key":"2098_CR16","first-page":"H1098","volume":"290","author":"X Yi","year":"2006","unstructured":"Yi X, Bekeredjian R, DeFilippis NJ, Siddiquee Z, Fernandez E, Shohet RV (2006) Transcriptional analysis of doxorubicin-induced cardiotoxicity. Am J Phys Heart Circ Phys 290(3):H1098\u2013H1102","journal-title":"Am J Phys Heart Circ Phys"},{"key":"2098_CR17","doi-asserted-by":"publisher","first-page":"745185","DOI":"10.5402\/2012\/745185","volume":"2012","author":"C Vasti","year":"2012","unstructured":"Vasti C, Witt H, Said M, Sorroche P, Garcia-Rivello H, Ruiz-Noppinger P, Hertig CM (2012) Doxorubicin and NRG-1\/erbB4-deficiency affect gene expression profile: involving protein homeostasis in mouse. ISRN cardiology 2012:745185\u2013745111","journal-title":"ISRN cardiology"},{"key":"2098_CR18","doi-asserted-by":"publisher","unstructured":"Gyongyosi M, Lukovic D, Zlabinger K, Spannbauer A, Gugerell A, Pavo N, Traxler D, Pils D, Maurer G, Jakab A, Riesenhuber M, Pircher A, Winkler J, Bergler-Klein J (2019) Liposomal doxorubicin attenuates cardiotoxicity via induction of interferon-related DNA damage resistance. Cardiovasc Res. https:\/\/doi.org\/10.1093\/cvr\/cvz192","DOI":"10.1093\/cvr\/cvz192"},{"key":"2098_CR19","doi-asserted-by":"publisher","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ (Clinical research ed):339. https:\/\/doi.org\/10.1136\/bmj.b2535","DOI":"10.1136\/bmj.b2535"},{"key":"2098_CR20","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1471-2288-14-43","volume":"14","author":"CR Hooijmans","year":"2014","unstructured":"Hooijmans CR, Rovers MM, de Vries RB, Leenaars M, Ritskes-Hoitinga M, Langendam MW (2014) SYRCLE\u2019s risk of bias tool for animal studies. BMC Med Res Methodol 14:43","journal-title":"BMC Med Res Methodol"},{"key":"2098_CR21","doi-asserted-by":"publisher","unstructured":"Cumpston M, Li T, Page MJ, Chandler J, Welch VA, Higgins JP, Thomas J (2019) Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions. The Cochrane database of systematic reviews 10:Ed000142. https:\/\/doi.org\/10.1002\/14651858.Ed000142","DOI":"10.1002\/14651858.Ed000142"},{"issue":"1","key":"2098_CR22","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1471-2288-14-25","volume":"14","author":"J IntHout","year":"2014","unstructured":"IntHout J, Ioannidis JPA, Borm GF (2014) The Hartung-Knapp-Sidik-Jonkman method for random effects meta-analysis is straightforward and considerably outperforms the standard DerSimonian-Laird method. BMC Med Res Methodol 14(1):25","journal-title":"BMC Med Res Methodol"},{"issue":"6","key":"2098_CR23","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.jacbts.2018.06.005","volume":"3","author":"AZ Luu","year":"2018","unstructured":"Luu AZ, Chowdhury B, Al-Omran M, Teoh H, Hess DA, Verma S (2018) Role of endothelium in doxorubicin-induced cardiomyopathy. JACC Basic to translational science 3(6):861\u2013870","journal-title":"JACC Basic to translational science"},{"issue":"10","key":"2098_CR24","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/j.healun.2009.06.025","volume":"28","author":"A Goetzenich","year":"2009","unstructured":"Goetzenich A, Hatam N, Zernecke A, Weber C, Czarnotta T, Autschbach R, Christiansen S (2009) Alteration of matrix metalloproteinases in selective left ventricular adriamycin-induced cardiomyopathy in the pig. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 28(10):1087\u20131093","journal-title":"The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation"},{"issue":"4","key":"2098_CR25","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1093\/cvr\/cvaa181","volume":"117","author":"C Gal\u00e1n-Arriola","year":"2020","unstructured":"Gal\u00e1n-Arriola C, Villena-Guti\u00e9rrez R, Higuero-Verdejo MI, D\u00edaz-Rengifo IA, Pizarro G, L\u00f3pez GJ, Ad M-I, P\u00e9rez-Mart\u00ednez C, Garc\u00eda RD, Gonz\u00e1lez-Calle D, Lobo M, S\u00e1nchez PL, Oliver E, C\u00f3rdoba R, Fuster V, S\u00e1nchez-Gonz\u00e1lez J, Ibanez B (2020) Remote ischaemic preconditioning ameliorates anthracycline-induced cardiotoxicity and preserves mitochondrial integrity. Cardiovasc Res 117(4):1132\u20131143","journal-title":"Cardiovasc Res"},{"key":"2098_CR26","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1016\/j.hlc.2018.08.003","volume":"28","author":"SP Levick","year":"2018","unstructured":"Levick SP, Soto-Pantoja DR, Bi J, Hundley WG, Widiapradja A, Manteufel EJ, Bradshaw TW, Melendez GC (2018) Doxorubicin-induced myocardial fibrosis involves the neurokinin-1 receptor and direct effects on cardiac fibroblasts. Heart, lung & circulation 28:1598\u20131605","journal-title":"Heart, lung & circulation"},{"issue":"4","key":"2098_CR27","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1002\/ejhf.1439","volume":"21","author":"M Russo","year":"2019","unstructured":"Russo M, Guida F, Paparo L, Trinchese G, Aitoro R, Avagliano C, Fiordelisi A, Napolitano F, Mercurio V, Sala V, Li M, Sorriento D, Ciccarelli M, Ghigo A, Hirsch E, Bianco R, Iaccarino G, Abete P, Bonaduce D, Calignano A, Berni Canani R, Tocchetti CG (2019) The novel butyrate derivative phenylalanine-butyramide protects from doxorubicin-induced cardiotoxicity. Eur J Heart Fail 21(4):519\u2013528","journal-title":"Eur J Heart Fail"},{"issue":"5","key":"2098_CR28","first-page":"H1236","volume":"315","author":"TA Johnson","year":"2018","unstructured":"Johnson TA, Singla DK (2018) PTEN inhibitor VO-OHpic attenuates inflammatory M1 macrophages and cardiac remodeling in doxorubicin-induced cardiomyopathy. Am J Phys Heart Circ Phys 315(5):H1236\u2013h1249","journal-title":"Am J Phys Heart Circ Phys"},{"issue":"3","key":"2098_CR29","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.yjmcc.2011.05.010","volume":"51","author":"GC van Almen","year":"2011","unstructured":"van Almen GC, Swinnen M, Carai P, Verhesen W, Cleutjens JP, D\u2019Hooge J, Verheyen FK, Pinto YM, Schroen B, Carmeliet P, Heymans S (2011) Absence of thrombospondin-2 increases cardiomyocyte damage and matrix disruption in doxorubicin-induced cardiomyopathy. J Mol Cell Cardiol 51(3):318\u2013328","journal-title":"J Mol Cell Cardiol"},{"issue":"4","key":"2098_CR30","doi-asserted-by":"publisher","first-page":"8168","DOI":"10.3390\/ijms16048168","volume":"16","author":"M Bartekova","year":"2015","unstructured":"Bartekova M, Simoncikova P, Fogarassyova M, Ivanova M, Okruhlicova L, Tribulova N, Dovinova I, Barancik M (2015) Quercetin improves postischemic recovery of heart function in doxorubicin-treated rats and prevents doxorubicin-induced matrix metalloproteinase-2 activation and apoptosis induction. Int J Mol Sci 16(4):8168\u20138185","journal-title":"Int J Mol Sci"},{"issue":"11","key":"2098_CR31","first-page":"21839","volume":"8","author":"L Zhou","year":"2015","unstructured":"Zhou L, Chen L, Wang J, Deng Y (2015) Astragalus polysaccharide improves cardiac function in doxorubicin-induced cardiomyopathy through ROS-p38 signaling. Int J Clin Exp Med 8(11):21839\u201321848","journal-title":"Int J Clin Exp Med"},{"issue":"5","key":"2098_CR32","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1161\/HYPERTENSIONAHA.106.077537","volume":"49","author":"N Koitabashi","year":"2007","unstructured":"Koitabashi N, Arai M, Kogure S, Niwano K, Watanabe A, Aoki Y, Maeno T, Nishida T, Kubota S, Takigawa M, Kurabayashi M (2007) Increased connective tissue growth factor relative to brain natriuretic peptide as a determinant of myocardial fibrosis. Hypertension (Dallas, Tex : 1979) 49(5):1120\u20131127","journal-title":"Hypertension (Dallas, Tex : 1979)"},{"issue":"3","key":"2098_CR33","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3390\/jcdd6030027","volume":"6","author":"NA Turner","year":"2019","unstructured":"Turner NA, Blythe NM (2019) Cardiac fibroblast p38 MAPK: a critical regulator of myocardial remodeling. Journal of cardiovascular development and disease 6(3):27","journal-title":"Journal of cardiovascular development and disease"},{"issue":"1","key":"2098_CR34","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1161\/CIRCRESAHA.112.266882","volume":"112","author":"FG Spinale","year":"2013","unstructured":"Spinale FG, Janicki JS, Zile MR (2013) Membrane-associated matrix proteolysis and heart failure. Circ Res 112(1):195\u2013208","journal-title":"Circ Res"},{"issue":"3","key":"2098_CR35","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.yjmcc.2009.09.013","volume":"48","author":"D Vanhoutte","year":"2010","unstructured":"Vanhoutte D, Heymans S (2010) TIMPs and cardiac remodeling: \u2018embracing the MMP-independent-side of the family\u2019. J Mol Cell Cardiol 48(3):445\u2013453","journal-title":"J Mol Cell Cardiol"},{"issue":"7","key":"2098_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0068154","volume":"8","author":"DH Lovett","year":"2013","unstructured":"Lovett DH, Mahimkar R, Raffai RL, Cape L, Zhu BQ, Jin ZQ, Baker AJ, Karliner JS (2013) N-terminal truncated intracellular matrix metalloproteinase-2 induces cardiomyocyte hypertrophy, inflammation and systolic heart failure. PLoS One 8(7):e68154. https:\/\/doi.org\/10.1371\/journal.pone.0068154","journal-title":"PLoS One"},{"key":"2098_CR37","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1146\/annurev.pharmtox.47.120505.105230","volume":"47","author":"R Schulz","year":"2007","unstructured":"Schulz R (2007) Intracellular targets of matrix metalloproteinase-2 in cardiac disease: rationale and therapeutic approaches. Annu Rev Pharmacol Toxicol 47:211\u2013242","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"2098_CR38","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1093\/cvr\/cvaa017","volume":"117","author":"BYH Chan","year":"2020","unstructured":"Chan BYH, Roczkowsky A, Cho WJ, Poirier M, Sergi C, Keschrumrus V, Churko JM, Granzier H, Schulz R (2020) MMP inhibitors attenuate doxorubicin cardiotoxicity by preventing intracellular and extracellular matrix remodeling. Cardiovasc Res 117:188\u2013200","journal-title":"Cardiovasc Res"},{"issue":"3","key":"2098_CR39","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.cardiores.2005.10.004","volume":"69","author":"AM Deschamps","year":"2006","unstructured":"Deschamps AM, Spinale FG (2006) Pathways of matrix metalloproteinase induction in heart failure: bioactive molecules and transcriptional regulation. Cardiovasc Res 69(3):666\u2013676","journal-title":"Cardiovasc Res"},{"issue":"1","key":"2098_CR40","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1023\/B:HREV.0000011393.40674.13","volume":"9","author":"DA Siwik","year":"2004","unstructured":"Siwik DA, Colucci WS (2004) Regulation of matrix metalloproteinases by cytokines and reactive oxygen\/nitrogen species in the myocardium. Heart Fail Rev 9(1):43\u201351","journal-title":"Heart Fail Rev"},{"issue":"5","key":"2098_CR41","doi-asserted-by":"publisher","first-page":"831","DOI":"10.33549\/physiolres.931797","volume":"59","author":"M Adamcova","year":"2010","unstructured":"Adamcova M, Potacova A, Popelova O, Sterba M, Mazurova Y, Aupperle H, Gersl V (2010) Cardiac remodeling and MMPs on the model of chronic daunorubicin-induced cardiomyopathy in rabbits. Physiol Res 59(5):831\u2013836","journal-title":"Physiol Res"},{"issue":"3-4","key":"2098_CR42","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s12079-009-0070-6","volume":"3","author":"MWM Schellings","year":"2009","unstructured":"Schellings MWM, van Almen GC, Sage EH, Heymans S (2009) Thrombospondins in the heart: potential functions in cardiac remodeling. Journal of cell communication and signaling 3(3-4):201\u2013213","journal-title":"Journal of cell communication and signaling"},{"issue":"5","key":"2098_CR43","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41569-019-0315-x","volume":"17","author":"L Adamo","year":"2020","unstructured":"Adamo L, Rocha-Resende C, Prabhu SD, Mann DL (2020) Reappraising the role of inflammation in heart failure. Nat Rev Cardiol 17(5):269\u2013285","journal-title":"Nat Rev Cardiol"},{"issue":"7 Pt B","key":"2098_CR44","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1016\/j.bbamcr.2016.01.021","volume":"1863","author":"A Ghigo","year":"2016","unstructured":"Ghigo A, Li M, Hirsch E (2016) New signal transduction paradigms in anthracycline-induced cardiotoxicity. Biochim Biophys Acta 1863(7 Pt B):1916\u20131925","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"2098_CR45","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.ejheart.2008.01.004","volume":"10","author":"A Riad","year":"2008","unstructured":"Riad A, Bien S, Gratz M, Escher F, Westermann D, Heimesaat MM, Bereswill S, Krieg T, Felix SB, Schultheiss HP, Kroemer HK, Tsch\u00f6pe C (2008) Toll-like receptor-4 deficiency attenuates doxorubicin-induced cardiomyopathy in mice. Eur J Heart Fail 10(3):233\u2013243","journal-title":"Eur J Heart Fail"},{"issue":"7","key":"2098_CR46","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1161\/hc3401.093154","volume":"104","author":"N Sivasubramanian","year":"2001","unstructured":"Sivasubramanian N, Coker ML, Kurrelmeyer KM, MacLellan WR, DeMayo FJ, Spinale FG, Mann DL (2001) Left ventricular remodeling in transgenic mice with cardiac restricted overexpression of tumor necrosis factor. Circulation 104(7):826\u2013831","journal-title":"Circulation"},{"issue":"19","key":"2098_CR47","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1161\/CIRCULATIONAHA.111.052399","volume":"124","author":"W Zhang","year":"2011","unstructured":"Zhang W, Chancey AL, Tzeng HP, Zhou Z, Lavine KJ, Gao F, Sivasubramanian N, Barger PM, Mann DL (2011) The development of myocardial fibrosis in transgenic mice with targeted overexpression of tumor necrosis factor requires mast cell-fibroblast interactions. Circulation 124(19):2106\u20132116","journal-title":"Circulation"},{"issue":"9","key":"2098_CR48","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1161\/CIRCRESAHA.110.226928","volume":"108","author":"JW Gordon","year":"2011","unstructured":"Gordon JW, Shaw JA, Kirshenbaum LA (2011) Multiple facets of NF-\u03baB in the heart: to be or not to NF-\u03baB. Circ Res 108(9):1122\u20131132","journal-title":"Circ Res"},{"issue":"3","key":"2098_CR49","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1161\/HYPERTENSIONAHA.113.02164","volume":"63","author":"D Wang","year":"2014","unstructured":"Wang D, Gladysheva IP, Fan TH, Sullivan R, Houng AK, Reed GL (2014) Atrial natriuretic peptide affects cardiac remodeling, function, heart failure, and survival in a mouse model of dilated cardiomyopathy. Hypertension (Dallas, Tex : 1979) 63(3):514\u2013519","journal-title":"Hypertension (Dallas, Tex : 1979)"},{"issue":"8","key":"2098_CR50","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1006\/jmcc.1999.0972","volume":"31","author":"JRJ Boucek","year":"1999","unstructured":"Boucek JRJ, Miracle A, Anderson M, Engelman R, Atkinson J, Dodd DA (1999) Persistent effects of doxorubicin on cardiac gene expression. J Mol Cell Cardiol 31(8):1435\u20131446","journal-title":"J Mol Cell Cardiol"},{"issue":"8","key":"2098_CR51","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1093\/eurjhf\/hfr080","volume":"13","author":"AH Chaanine","year":"2011","unstructured":"Chaanine AH, Hajjar RJ (2011) AKT signalling in the failing heart. Eur J Heart Fail 13(8):825\u2013829","journal-title":"Eur J Heart Fail"},{"issue":"8","key":"2098_CR52","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/nrm1983","volume":"7","author":"J Heineke","year":"2006","unstructured":"Heineke J, Molkentin JD (2006) Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat Rev Mol Cell Biol 7(8):589\u2013600","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2098_CR53","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.yjmcc.2015.11.016","volume":"93","author":"J Hartupee","year":"2016","unstructured":"Hartupee J, Mann DL (2016) Role of inflammatory cells in fibroblast activation. J Mol Cell Cardiol 93:143\u2013148","journal-title":"J Mol Cell Cardiol"},{"issue":"2","key":"2098_CR54","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1093\/cvr\/cvu062","volume":"102","author":"S Van Linthout","year":"2014","unstructured":"Van Linthout S, Miteva K, Tsch\u00f6pe C (2014) Crosstalk between fibroblasts and inflammatory cells. Cardiovasc Res 102(2):258\u2013269","journal-title":"Cardiovasc Res"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-021-02098-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00109-021-02098-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-021-02098-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T09:05:52Z","timestamp":1629104752000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00109-021-02098-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,29]]},"references-count":54,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["2098"],"URL":"https:\/\/doi.org\/10.1007\/s00109-021-02098-8","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,29]]},"assertion":[{"value":"19 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}